Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Laurent Décosterd"'
Autor:
Eva Choong, Alain Sauty, Angela Koutsokera, Sylvain Blanchon, Pascal André, Laurent Decosterd
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1674 (2022)
Drugs modulating the cystic fibrosis transmembrane conductance regulator (CFTR) protein, namely ivacaftor, lumacaftor, tezacaftor, and elexacaftor, are currently revolutionizing the management of patients with cystic fibrosis (CF), particularly those
Externí odkaz:
https://doaj.org/article/c39febd2b9914d9b9cd7389ea3d26fc2
Autor:
François Chappuis, Idris Guessous, Thomas Perneger, Manuel Battegay, Laurent Kaiser, Mikaela Smit, Frederique Jacquerioz, Annalisa Marinosci, Giovanni Jacopo Nicoletti, Silvio Ragozzino, Diego O Andrey, Dan Lebowitz, Benjamin Meyer, Herve Spechbach, Julien Salamun, Moritz Back, Carla Schaubhut, Simon Fuchs, Laurent Decosterd, Niklaus D Labhardt
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Introduction Lopinavir/ritonavir (LPV/r) has been proposed as repurposed drugs for pre-exposure and postexposure prophylaxis as well as therapy of COVID-19. Coronavirus postexposure prophylaxis (COPEP) trial aims at assessing their efficacy as postex
Externí odkaz:
https://doaj.org/article/8d97a7d7d47d435ab1a87d68fdbcfb5b
Autor:
Rajeev K. Tyagi, Patrick J. Gleeson, Ludovic Arnold, Rachida Tahar, Eric Prieur, Laurent Decosterd, Jean-Louis Pérignon, Piero Olliaro, Pierre Druilhe
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-19 (2018)
Abstract Background Humanity has become largely dependent on artemisinin derivatives for both the treatment and control of malaria, with few alternatives available. A Plasmodium falciparum phenotype with delayed parasite clearance during artemisinin-
Externí odkaz:
https://doaj.org/article/10d1bab21c5c413dbc48428c362b380e
Autor:
Corinne Ruppen, Thomas Mercier, Denis Grandgirard, Stephen L. Leib, Cristina El Haj, Oscar Murillo, Laurent Decosterd, Parham Sendi
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
The rate of invasive group B Streptococcus (GBS) infections is steadily increasing, particularly in older persons and in adults with diabetes and other comorbidities. This population includes persons with a foreign body (e.g., who have undergone arth
Externí odkaz:
https://doaj.org/article/374e7e1398dd4f319d0b4c15f6322758
Autor:
Susanne Helena Hodgson, David Llewellyn, Sarah Silk, Kathryn H Milne, Sean C Elias, Kazutoyo Miura, Gathoni Kamuyu, Elizabeth Juma, Charles Magiri, Alfred Musau Muia, Jing Jin, Alexandra J Spencer, Rhea Jessica Longley, Thomas Mercier, Laurent Decosterd, Carole A Long, Faith HA Osier, Stephen Hoffman, Bernhards Ragama Ogutu, Adrian V.S. Hill, Kevin Marsh, Simon J Draper
Publikováno v:
Frontiers in Microbiology, Vol 7 (2016)
Background: The timing of infection is closely determined in controlled human malaria infection (CHMI) studies, and as such they provide a unique opportunity to dissect changes in immunological responses before and after a single infection. The first
Externí odkaz:
https://doaj.org/article/550880d79dd64b4f9ce906d28573e21b
Autor:
Oriane Sottas, Monia Guidi, Benjamin Thieffry, Marie Schneider, Laurent Décosterd, Ivo Mueller, Blaise Genton, Chantal Csajka, Nicolas Senn
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0210789 (2019)
BackgroundThe intermittent preventive treatment in infants (IPTi) trial that took place in Papua New Guinea showed an overall reduction of 29% of the risk of malaria when delivering single-dose sulfadoxine-pyrimethamine (SP) associated to 3 days of a
Externí odkaz:
https://doaj.org/article/6041fc9ebc5d4238a65e9fedcf41156d
Autor:
Annalisa Marinosci, Delphine Sculier, Gilles Wandeler, Sabine Yerly, Marcel Stoeckle, Enos Bernasconi, Dominique L. Braun, Pietro Vernazza, Matthias Cavassini, Marta Buzzi, Karin J. Metzner, Laurent Decosterd, Huldrych F. Günthard, Patrick Schmid, Andreas Limacher, Mattia Branca, Alexandra Calmy
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 4 (2024)
BACKGROUND: Clinical and laboratory monitoring of patients on antiretroviral therapy is an integral part of HIV care and determines whether treatment needs enhanced adherence or modification of the drug regimen. However, different monitoring and trea
Externí odkaz:
https://doaj.org/article/ca57416c5ab3455b9886cc7eb487bff3
Autor:
Carole Bandiera, Evelina Cardoso, Isabella Locatelli, Antonia Digklia, Khalil Zaman, Antonella Diciolla, Valérie Cristina, Athina Stravodimou, Aedo Lopez Veronica, Ana Dolcan, Apostolos Sarivalasis, Aikaterini Liapi, Hasna Bouchaab, Angela Orcurto, Jennifer Dotta-Celio, Solange Peters, Laurent Decosterd, Nicolas Widmer, Dorothea Wagner, Chantal Csajka, Marie Paule Schneider
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 6, p e30090 (2021)
BackgroundThe strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase inhibitors (PKIs), has provided impressive clinical benefits and autonomy as well as a better quali
Externí odkaz:
https://doaj.org/article/04775837df1f491490dee20da4b49c14
Publikováno v:
Frontiers in Microbiology, Vol 7 (2016)
Group B Streptococcus (GBS) is increasingly causing invasive infections in nonpregnant adults. Elderly patients and those with comorbidities are at increased risk. On the basis of previous studies focusing on neonatal infections, penicillin plus gent
Externí odkaz:
https://doaj.org/article/5dfb748fbadd4939b7c3a32f5a79db59
Autor:
Dominique L Braun, Andri Rauch, Manel Aouri, Nina Durisch, Nadia Eberhard, Alexia Anagnostopoulos, Bruno Ledergerber, Beat Müllhaupt, Karin J Metzner, Laurent Decosterd, Jürg Böni, Rainer Weber, Jan Fehr, Swiss HIV Cohort Study
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133028 (2015)
The efficacy of first-generation protease inhibitor based triple-therapy against hepatitis C virus (HCV) infection is limited in HIV/HCV-coinfected patients with advanced liver fibrosis and non-response to previous peginterferon-ribavirin. These pati
Externí odkaz:
https://doaj.org/article/592defcac282419085300e63d729b6d5